We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SKYT:NASDAQSkyWater Technology, Inc. Analysis

Data as of 2026-05-01 - not real-time

$31.90

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

SkyWater Technology (SKYT) is trading in a bullish technical environment, with price holding above both its short‑term (20‑day) and intermediate (50‑day) moving averages and comfortably above the identified support zone. Momentum indicators are mixed – RSI sits in the neutral range and the MACD histogram has turned negative, suggesting short‑term caution, while the overall trend remains bullish. Fundamentally, the stock appears cheap relative to its semiconductor peers, posting a PE well below the industry average, but it carries a heavy debt load, negative operating cash flow, and high 30‑day volatility.
Recent market activity shows the share price out‑performing the broader tech sector over the past month and an analyst consensus of “hold” with a target price implying modest upside. However, the extreme greed sentiment and a beta well above one indicate that price swings could be amplified, especially if broader market sentiment shifts.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Mixed MACD signal and decreasing volume suggest caution
  • High beta and elevated volatility increase price swing risk
  • Price is near support but still above short‑term averages

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Valuation gap with industry (low PE) offers upside to target price
  • Revenue growth and exposure to high‑margin defense/quantum segments
  • Analyst median target price indicates ~10% upside

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Heavy debt and negative cash flow constrain long‑term financial flexibility
  • Strategic positioning in U.S. semiconductor supply chain supports stability
  • Sector demand for specialty and advanced packaging remains robust

Key Metrics & Analysis

Financial Health

Revenue Growth126.60%
Profit Margin26.89%
P/E Ratio13.1
ROE95.94%
ROA-0.31%
Debt/Equity127.85
P/B Ratio8.3
Op. Cash Flow$-28966000
Free Cash Flow$-38568624
Industry P/E37.9

Technical Analysis

TrendBullish
RSI55.6
Support$26.57
Resistance$34.40
MA 20$31.14
MA 50$29.47
MA 200$20.96
MACDBearish
VolumeDecreasing
Fear & Greed Index90.95

Valuation

Target Price$35.00
Upside/Downside9.72%
GradeFair
TypeBlend

Risk Assessment

Beta2.68
Volatility47.12%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.